Progressive CKD is generally detected at a late stage by a sustained decline in eGFR and/or
the presence of significant albuminuria. With the aim of early and improved risk stratification …

Urinary proteomic biomarkers have emerged as clinically relevant variables. First studies
involving several hundred individuals indicate a potential added benefit of urinary proteomic …

Eur J Clin Invest 2012; 42 (9): 1027–1036 Abstract While large numbers of proteomic
biomarkers have been described, they are generally not implemented in medical practice …

A previous meta-analysis of genome-wide association data by the Cohorts for Heart and
Aging Research in Genomic Epidemiology and CKDGen consortia identified 16 loci …

The improvement of long‐term transplant organ and patient survival remains a critical
challenge following kidney transplantation. Proteomics and biochemical profiling …

Methods A retrospective analysis of the K-STAR data was performed including 383 patients
with CKD (mean age, 56.4 years; male/female, 252/131). We measured circulating renalase …

Here we report a metabolomics discovery study conducted on blood serum samples of
patients in different stages of chronic kidney disease (CKD). Metabolites were monitored on …

Background An improvement in the glomerular filtration rate (GFR) of chronic kidney disease
patients has been an underestimated clinical outcome. Although this may be considered as …

The emergence of artificial intelligence and machine learning (ML) has revolutionized the
landscape of clinical medicine, offering opportunities to improve medical practice and …

Previously, variation in retinal vascular caliber has been reported in association with chronic
kidney disease (CKD) but findings remain inconsistent. To help clarify this we conducted …